LYOPHILIZED PHARMACEUTICAL COMPOSITION OF NEOCARZINOSTATIN DERIVATIVE

摘要

A lyophilized pharmaceutical composition is produced by dissolving a neocarzinostatin derivative and at least one specific saccharide into a buffer solution, and sterilizing by filtration and lyophilizing the resulting solution after pH adjustment.